Commercialised prostate cancer diagnostic testsBiomarkersProstate specific antigen historyMultiplexingPoint-of-care devicesThe increased incidence and the significant health burden associated with carcinoma of the prostate have led to substantial changes in its diagnosis over the past century. Despite ...
The goal and purpose is to be the source for molecular diagnostic UTI and prostate cancer tests to as many health care providers and patients as possible, in turn saving lives and providing a rapid return to health. Everett Research provides the highest quality UTI and prostate cancer screening...
Prostate cancer: Does uptake of technology promote diagnostic testing?doi:10.1038/nrurol.2013.123NoneNature Reviews Urology
When a screening indicates elevated PSA levels or other concerns, DPC providers work closely with patients to design a care plan that addresses the unique aspects of their condition, whether it involves prostate biopsies, further diagnostic tests like an MRI, or discussions on prostate cancer ...
Imaging modalities like magnetic resonance imaging (MRI) and ultrasound can also be applied to assess the size, shape, and possible spread of cancer of the prostate. These diagnostic tests determine the stage and grade of cancer, influencing treatment. Early and precise detection by prostate cancer...
Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for men presenting with suspected prostate cancer, with a negative MRI enabling safe avoidance of biopsy and a positive result enabling MRI-directed sampling of lesions. The diagnostic pathway consists of several step...
At Check4Cancer we want to empower you to take control of your health and we are committed to providing you with clinical excellence in all our cancer screening and diagnostic services. Our team consists of cancer specialists and highly trained support staff, here to help and guide you. Take...
Résumé des cinq études ayant évalué l’intérêt diagnostique de la mesure du score PCA3 dans les urines pour le diagnostic du cancer de la prostate. RéférencesOrigine de la populationNombre de patientsNombre d’échantillons informatifs (%), dont cancers (%)AUCSe (%)Sp (%)VPP (%)...
In all, 330 men participating in the prostate testing for cancer and treatment (ProtecT) study were studied; aged 50–69 years with a PSA level of⩾3 ng ml−1and a negative biopsy result. Distress and negative mood were measured at four time-points: two during diagnostic testing an...
Several key themes have emerged, including invitation policies, shared decision-making strategies, diagnostic tests and algorithms. While many areas remain contentious and require further investigation, this document, along with other initiatives from the European Association of Urology-led PRostate cancer ...